1689P Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials
Gulley, J., Lacouture, M.E., Spira, A., Mata, H. Verdaguer, Yoo, C., Cho, B.C., Helwig, C., Halady, T., Valencia, C., Bajars, M., Strauss, J., Brownell, I.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
P-183 Neoadjuvant treatment in borderline resectable pancreatic adenocarcinoma (PA): A single center series
Verdaguer Mata, H., Laquente, B., Busquets, J., Pelaez, N., Secanella, L., Leiva, D., Ruiz, S., Peiro, I., Lopez Urdiales, R., Serrano, T., Vazquez, S., Calvo, M., Serra, O., Cambray, M., Perez Martin, F.J., Sanchez, C., Galan, M., Fabregat, J.
Published in Annals of oncology (01.06.2015)
Published in Annals of oncology (01.06.2015)
Get full text
Journal Article